• Incyte EVP and Chief Scientific Officer Patrick A. Mayes sold 2,207 shares on Aug. 5 at USD 123.99.
• Mayes exercised employee stock options for 2,207 shares at USD 106.47 on the same day.
• Directly held common shares fell to 61,441 following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002079962-26-000015), on August 07, 2026, and is solely responsible for the information contained therein.